These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7067469)
1. Early stopping in the two-sample problem for bounded random variables. DeMets DL; Halperin M Control Clin Trials; 1982 Mar; 3(1):1-11. PubMed ID: 7067469 [TBL] [Abstract][Full Text] [Related]
2. A note on data monitoring, incomplete data and curtailed testing. Pasternack BS Control Clin Trials; 1984 Sep; 5(3):217-22. PubMed ID: 6488806 [TBL] [Abstract][Full Text] [Related]
3. Sample size graphs for "proving the null hypothesis". Blackwelder WC; Chang MA Control Clin Trials; 1984 Jun; 5(2):97-105. PubMed ID: 6744888 [TBL] [Abstract][Full Text] [Related]
4. Properties of simple randomization in clinical trials. Lachin JM Control Clin Trials; 1988 Dec; 9(4):312-26. PubMed ID: 3203523 [TBL] [Abstract][Full Text] [Related]
5. Properties of the urn randomization in clinical trials. Wei LJ; Lachin JM Control Clin Trials; 1988 Dec; 9(4):345-64. PubMed ID: 3203525 [TBL] [Abstract][Full Text] [Related]
6. Early termination of clinical trials with prolonged observation of individual patients: a case study. van Es GA; Tijssen JG; Lubsen J; van Strik R Stat Med; 1987 Dec; 6(8):927-37. PubMed ID: 3438618 [TBL] [Abstract][Full Text] [Related]
7. On design considerations and randomization-based inference for community intervention trials. Gail MH; Mark SD; Carroll RJ; Green SB; Pee D Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140 [TBL] [Abstract][Full Text] [Related]
8. Sequential stopping rules and sequentially adjusted P values: does one require the other? Dupont WD Control Clin Trials; 1983 Mar; 4(1):3-10. PubMed ID: 6851579 [TBL] [Abstract][Full Text] [Related]
9. Optimal two-stage designs for clinical trials with binary response. Thall PF; Simon R; Ellenberg SS; Shrager R Stat Med; 1988 May; 7(5):571-9. PubMed ID: 3387716 [TBL] [Abstract][Full Text] [Related]
10. Randomization in clinical trials: conclusions and recommendations. Lachin JM; Matts JP; Wei LJ Control Clin Trials; 1988 Dec; 9(4):365-74. PubMed ID: 3203526 [TBL] [Abstract][Full Text] [Related]
11. Explanatory and pragmatic estimates of the treatment effect when deviations from allocated treatment occur. Newcombe RG Stat Med; 1988 Nov; 7(11):1179-86. PubMed ID: 3201044 [TBL] [Abstract][Full Text] [Related]
12. Statistical properties of randomization in clinical trials. Lachin JM Control Clin Trials; 1988 Dec; 9(4):289-311. PubMed ID: 3060315 [TBL] [Abstract][Full Text] [Related]
13. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning. Schmidt R; Burkhardt B; Faldum A Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500 [TBL] [Abstract][Full Text] [Related]
15. Operating characteristics of sample size re-estimation with futility stopping based on conditional power. Lachin JM Stat Med; 2006 Oct; 25(19):3348-65. PubMed ID: 16345019 [TBL] [Abstract][Full Text] [Related]
16. When does the failure to find a difference mean that there is none? Javitt JC Arch Ophthalmol; 1989 Jul; 107(7):1034-40. PubMed ID: 2568828 [TBL] [Abstract][Full Text] [Related]
17. Planning the size of survival time clinical trials with allowance for stratification. Moussa MA Stat Med; 1988 May; 7(5):559-69. PubMed ID: 3387715 [TBL] [Abstract][Full Text] [Related]
19. Effects of correlation and missing data on sample size estimation in longitudinal clinical trials. Zhang S; Ahn C Pharm Stat; 2010; 9(1):2-9. PubMed ID: 19053162 [TBL] [Abstract][Full Text] [Related]
20. "Proving the null hypothesis" in clinical trials. Blackwelder WC Control Clin Trials; 1982 Dec; 3(4):345-53. PubMed ID: 7160191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]